bioAffinity Technologies (BIAFW) Current Ratio

Price: $2
Market Cap: $26.98M
Avg Volume: -
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 2.934
52W Range: $1.29-2.44
Website: bioAffinity Technologies

bioAffinity Technologies Current Ratio

  • Annual: 1.77
  • Quarterly: 1.15
  • TTM: 1.15

What is the Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay off its short-term liabilities with its short-term assets. A higher current ratio indicates a greater ability to meet short-term obligations.

Related Metrics

Other important metrics to assess bioAffinity Technologies's financial health include:

  • Quick Ratio - measures the company's ability to meet short-term obligations with its most liquid assets:
    • Annual: 1.76
    • Quarterly: 1.14
    • TTM: 1.14
  • Cash Ratio - measures the company's ability to pay off short-term liabilities with cash and cash equivalents:
    • Annual: 1.26
    • Quarterly: 0.34
    • TTM: 0.34

These metrics provide insights into bioAffinity Technologies's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Current Ratio

1.77

Quarterly Current Ratio

1.15

TTM Current Ratio

1.15

bioAffinity Technologies Historical Current Ratio
Historical Quick Ratio
Historical Cash Ratio

bioAffinity Technologies Historical Ratios

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year Current Ratio Quick Ratio Cash Ratio
2023 1.77 1.76 1.26
2022 10.50 10.50 10.02
2021 0.11 0.10 0.10
2020 0.01 0.01 0.01
2019 0.13 0.13 0.12